Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
ObjectiveGestational diabetes mellitus (GDM) is one of the most common complications during pregnancy. There is inconsistency between previous studies regarding the blood and inflammatory parameters levels among pregnant women and its association with GDM. This study aimed to investigate the relationship between blood parameters in relation to GDM.MethodsSystematic literature searches were carried out through databases like PubMed, Web of Science, Epistemonikos, Scopus, Scientific Information Database and Magiran till May 2024. The effect size of serum blood parameters levels was determined by using standard mean deviations (SMDs) and 95% confidence intervals (CIs).ResultsThirty articles were included in this study. Meta‐analysis showed that compared with the control group, women with GDM had significantly higher levels of haemoglobin (0.343 [95% CI 0.134–0.553] p = 0.01, sensitivity analysis: 0.174 [95% CI 0.0343–0.315] p = 0.01), red blood cell (0.387 [95% CI 0.224–0.550] p < 0.001), mean platelet volume (0.498 [95% CI 0.165–0.831] p = 0.003), white blood cell count (0.351 [95% CI 0.0882–0.615] p = 0.009) and neutrophil–lymphocyte ratio (0.534 [95% CI 0.127–0.941] p = 0.01). However, women with GDM had lower levels of mean corpuscular haemoglobin concentration (−0.249 [95% CI −0.386–−0.112] p < 0.001). Pooled results from MPV showed no association between adjusted MPV and GDM (adjusted OR 1.33 [95% CI 0.8–1.86] I2 = 57.2%).ConclusionsFinding supports higher levels of blood parameters (Hb, RBC, WBC, NLR and MPV) among women with GDM in the second trimester of pregnancy. Future studies should investigate the potential role of these haematological markers as predictive tools for adverse pregnancy outcomes and evaluate therapeutic interventions targeting these parameters to enhance maternal and fetal health.
ObjectiveGestational diabetes mellitus (GDM) is one of the most common complications during pregnancy. There is inconsistency between previous studies regarding the blood and inflammatory parameters levels among pregnant women and its association with GDM. This study aimed to investigate the relationship between blood parameters in relation to GDM.MethodsSystematic literature searches were carried out through databases like PubMed, Web of Science, Epistemonikos, Scopus, Scientific Information Database and Magiran till May 2024. The effect size of serum blood parameters levels was determined by using standard mean deviations (SMDs) and 95% confidence intervals (CIs).ResultsThirty articles were included in this study. Meta‐analysis showed that compared with the control group, women with GDM had significantly higher levels of haemoglobin (0.343 [95% CI 0.134–0.553] p = 0.01, sensitivity analysis: 0.174 [95% CI 0.0343–0.315] p = 0.01), red blood cell (0.387 [95% CI 0.224–0.550] p < 0.001), mean platelet volume (0.498 [95% CI 0.165–0.831] p = 0.003), white blood cell count (0.351 [95% CI 0.0882–0.615] p = 0.009) and neutrophil–lymphocyte ratio (0.534 [95% CI 0.127–0.941] p = 0.01). However, women with GDM had lower levels of mean corpuscular haemoglobin concentration (−0.249 [95% CI −0.386–−0.112] p < 0.001). Pooled results from MPV showed no association between adjusted MPV and GDM (adjusted OR 1.33 [95% CI 0.8–1.86] I2 = 57.2%).ConclusionsFinding supports higher levels of blood parameters (Hb, RBC, WBC, NLR and MPV) among women with GDM in the second trimester of pregnancy. Future studies should investigate the potential role of these haematological markers as predictive tools for adverse pregnancy outcomes and evaluate therapeutic interventions targeting these parameters to enhance maternal and fetal health.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.